The most developed technology platform with a variety of applications, including infectious disease detection, fertility detection, the drug of abuse detection, etc.
50+ kinds of reagents and five high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
Wondfo optical blood coagulation analyzer is the first one in the world that can test PT, APTT, TT, FIB, and ACT simultaneously.
Our Blood Gas Analyzer BGA-102 can produce the result in 30s. Its advantages of portability, easy operation, durability, and high performance make it ideal for clinics, laboratories, and hospitals.
Wondfo Dry Chemistry Analyzer can test 16 items and provide the result within 2 minutes, ideal for the detection of cardiac markers, kidney function, liver function, pancreatitis, etc.
Ready-to-use lyophilized RT-PCR Reagent;
Gold Standard for COVID-19 Diagnosis
Building Cardiovascular Health Together, See You at ISTH 2024!
May 17,2024 (Edit) Wondfo
The 32nd International Society on Thrombosis and Hemostasis (ISTH) Annual Congress will be held in Bangkok, Thailand from June 22nd to 26th, 2024. Wondfo booth is #809.
Wondfo will be the one and only Chinese brand participating in the conference. In the field of coagulation testing, Wondfo plans to present the new chemiluminescence series and our first batch of thrombosis early screening project.
As a globally recognized academic organization dedicated to coagulation and hemostasis, the ISTH aims to advance understanding, prevention, diagnosis, and treatment of thrombotic and hemorrhagic disorders. With a membership spanning over 100 countries and consisting of more than 7,000 individuals, including doctors, scientists, nurses, technicians, and other professionals from around the world, the ISTH has become a leading authority in the field.
The ISTH Congress has evolved into the most influential international gathering in the fields of thrombosis and hemostasis, attracting thousands of world-class experts in thrombosis, hemostasis, and vascular biology fields annually. It serves as a platform to showcase the latest research findings, exchange scientific discoveries, enhance the latest clinical applications for patient care, and promote comprehensive understanding, prevention, diagnosis, and treatment of thrombotic and hemorrhagic disorders.
As the one and only Chinese brand participating in this conference, Wondfo will present solutions in the field of thrombosis and hemostasis testing. The new Smarlumi™ series of chemiluminescence platform-FC-2100 will make its debut overseas.
As early 2020, Wondfo launched the first batch of thrombosis early screening projects in China, 4 markers of Thrombosis Diagnosis-PT, APTT, FIB, TT. Leveraging both chemiluminescence and electrochemistry platform technologies, Wondfo developed a comprehensive and flexible solution for coagulation disease detection, addressing challenges in managing critical coagulation disorders in emergency situations.